RETRACTED ARTICLE: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells

Dan Yue, Xiaosong Qin

DOI: 10.1038/s41417-018-0031-4
Published: 2018-06-21
Container: Cancer Gene Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41417-018-0031-4,
  title = {RETRACTED ARTICLE: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells},
  author = {Dan Yue and Xiaosong Qin},
  year = {2018},
  journal = {Cancer Gene Therapy},
  doi = {10.1038/s41417-018-0031-4},
  url = {https://doi.org/10.1038/s41417-018-0031-4}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells
AU  - Dan Yue
AU  - Xiaosong Qin
PY  - 2018
JO  - Cancer Gene Therapy
DO  - 10.1038/s41417-018-0031-4
UR  - https://doi.org/10.1038/s41417-018-0031-4
ER  -

APA

Yue, D., & Qin, X. (2018). RETRACTED ARTICLE: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells. Cancer Gene Therapy. https://doi.org/10.1038/s41417-018-0031-4

Source records

crossref · retrieved 2026-09-25T21:09:14.788Z